Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14782956 | 0.87 | CDK1 (0.33) | — | |
| SCHEMBL28082047 | 0.78 | FAAH (0.33) | — | |
| SCHEMBL737125 | 0.76 | — | — | |
| SCHEMBL23837700 | 0.75 | AOC1 (0.38) | MEN1NPC1RAB9AKMT2AATM | |
| SCHEMBL6762869 | 0.75 | MEN1 (0.33) | MEN1NPC1RAB9AKMT2AATM | |
| SCHEMBL6159326 | 0.75 | MEN1 (0.33) | MEN1NPC1RAB9AKMT2AATM | |
| SCHEMBL20189661 | 0.75 | PDE2A (0.33) | PDE2A | |
| SCHEMBL20189663 | 0.75 | PDE2A (0.33) | PDE2A | |
| SCHEMBL256048 | 0.75 | NPC1 (0.62) | MEN1NPC1RAB9AKMT2AATM | |
| SCHEMBL456987 | 0.75 | NPC1 (0.62) | MEN1NPC1RAB9AKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339907-A1 | PROCESS FOR THE PREPARATION OF QUATERNIZED PYRIDAZINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339907-A1 | PROCESS FOR THE PREPARATION OF QUATERNIZED PYRIDAZINE DERIVATIVES | DHPS, PDXK, NQO1 | PDE2A 1226/4885MEN1 931/4885NPC1 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.